The findings in vivo further indicated that CDR1as acted as an oncogene, up-regulating the proliferation index Ki-67, EGFR, CCNE1, and PIK3CD levels, thus inhibiting the anti-tumor effects of tumor suppressor miR-7 [94,95,96,97]. The gene discussed is CCNE1; the disease is neoplasm.